Scientific Publications Search Search Author Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Birchmeier-Kohler, Carmen Prof. Dr. (1) Haseleu, Julia Dr. (1) Jüttner, Rene Dr. (2) Kühn, Ralf Dr. (1) Lewin, Gary Prof. Dr. (1) Müller, Thomas Dr. (1) Poulet, James Prof. Dr. (1) Rathjen, Fritz Prof. Dr. (7) (-) Paul, Friedemann Prof. Dr. med. (1) (-) Siffrin, Volker (2) 2005 (1) 2007 (1) 2009 (4) 2010 (5) 2012 (1) 2013 (5) 2014 (5) 2015 (6) 2016 (4) 2017 (3) (-) 2018 (2) 2021 (4) 2023 (5) 2024 (1) AG Müller/Dechend (ECRC) (6) Animal Phenotyping (3) Bioinformatics and Omics Data Science (1) Biology of Malignant Lymphomas (1) Experimental Ultrahigh-Field MR (2) Hypertension-caused End-Organ Damage (6) Hypertension-Mediated End-Organ Damage (6) Interdisciplinary Retina Research (10) Magnetic Resonance (2) Molecular Biology of Peptide Hormones (48) Molecular Cardiovascular Research (1) Molecular Physiology of Somatic Sensation (1) Myology (1) (-) Neuroimmunology Laboratory (2) Out-patient Clinic for Neuroimmunology (57) Pathogenesis of ANCAinduced Glomerulonephritis (10) Proteomics (1) Translational Neuroimmunology (5) Translational Oncology of Solid Tumors (1) 2 Results: Active Filter: Paul, Friedemann Prof. Dr. med.Siffrin, VolkerNeuroimmunology Laboratory 2018 Sort: Result score Newest to oldest Oldest to newest April 15, 2018 / J Immunol CCR7 on CD4(+) T cells plays a crucial role in the induction of experimental autoimmune encephalomyelitis P. Belikan U. Bühler C. Wolf G.K. Pramanik R. Gollan F. Zipp V. Siffrin October 01, 2018 / Front Neurol Disease modification in multiple sclerosis by flupirtine - results of a randomized placebo controlled phase II trial J. Dörr K.D. Wernecke J. Würfel J. Bellmann-Strobl V. Siffrin M.B. Sättler M. Simons A. Linsa H. Tumani F. Paul
April 15, 2018 / J Immunol CCR7 on CD4(+) T cells plays a crucial role in the induction of experimental autoimmune encephalomyelitis P. Belikan U. Bühler C. Wolf G.K. Pramanik R. Gollan F. Zipp V. Siffrin
October 01, 2018 / Front Neurol Disease modification in multiple sclerosis by flupirtine - results of a randomized placebo controlled phase II trial J. Dörr K.D. Wernecke J. Würfel J. Bellmann-Strobl V. Siffrin M.B. Sättler M. Simons A. Linsa H. Tumani F. Paul